Mohammed Najeeb Al Hallak, MD, MS

Dr. Najeeb Al Hallak is a GI Medical Oncologist at the Karmanos Cancer Institute located in Detroit, MI. He is the Co-Leader of the Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team and a member of the Phase 1 Therapeutics Program. Dr. Al Hallak serves as the EMR Physician Champion, is a member of the Clinical Leadership Council, Medical Executive Committee, and Data Safety Monitoring Committee, and is the Program Director for the Annual Gastrointestinal Oncology Symposium at KCI. He is an Associate Professor in the Department of Oncology at the Wayne State University School of Medicine. Dedicated to teaching the next generation of Physicians and Researchers, he was honored with  the Physician Scientist-Research Excellence Award and College Teaching Award in 2023.

With a research focus on Gastrointestinal Malignancies, specifically Pancreatic Cancer, Dr. Al Hallak’s goal is to better understand the molecular biology and microenvironment of GI cancers, discover new treatments and prevent treatment-induced toxicities. He translates his passion for improving treatment outcomes for GI cancer patients by conducting Clinical Trials (phase I-III) and is currently the Principal Investigator on many important active trials. Dr. Al Hallak works through translational research to identify new biomarkers that help to individualize the treatment choice for his patients and provide them with an accurate prediction of the treatment effect as well as a prognosis of their cancer.